GlaxoSmithKline (GSK) Assets US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Assets, £ | 60 146 000 000 | 60 146 000 000 | 60 146 000 000 | 59 005 000 000 | 59 005 000 000 | 58 049 000 000 | |||
| Changes by years, y/y, % | -24% | 0% | 0% | -2% | 0% | +0.3% | |||
GlaxoSmithKline. Assets, £
GlaxoSmithKline. Assets, changes, %
GlaxoSmithKline (GSK) Assets US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| Assets, £ | 58 511 000 000 | 58 066 000 000 | 58 066 000 000 | 58 049 000 000 | 58 049 000 000 | 58 049 000 000 | ||
| Changes by years, y/y, % | 0% | -2% | -2% | -5% | -5% | |||
| Changes by quarters, q/q, % | -1% | -1% | 0% | 0% | 0% | |||